Contrary to the expectation that reduced FGF2 levels would worsen the phenotype of ALS, FGF2 deficiency significantly delayed disease onset and improved impaired motor performance in mutant SOD1 mice, a common ALS model [178]. Here, SOD1 is linked to amyotrophic lateral sclerosis.